(ORMP) Oramed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Oramed Pharmaceuticals | (ORMP) share price targets
Complete technical analysis of Oramed Pharmaceuticals (ORMP) by charts plus indicators, forecast predictions and share price targets for Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-19 View latest technical analysis
10 day averaged volume of Oramed Pharmaceuticals is 125513
Date | Daily Closing Price | Open | High | Low | Volume |
19 Mon Aug 2024 | 2.37 | 2.34 | 2.44 | 2.31 | 0.954 times |
16 Fri Aug 2024 | 2.34 | 2.34 | 2.48 | 2.32 | 2.357 times |
15 Thu Aug 2024 | 2.35 | 2.40 | 2.40 | 2.28 | 0.957 times |
14 Wed Aug 2024 | 2.24 | 2.34 | 2.43 | 2.23 | 1.215 times |
13 Tue Aug 2024 | 2.36 | 2.35 | 2.43 | 2.30 | 0.496 times |
12 Mon Aug 2024 | 2.32 | 2.26 | 2.43 | 2.26 | 0.697 times |
09 Fri Aug 2024 | 2.34 | 2.34 | 2.38 | 2.31 | 0.48 times |
08 Thu Aug 2024 | 2.37 | 2.27 | 2.40 | 2.22 | 0.951 times |
07 Wed Aug 2024 | 2.21 | 2.35 | 2.35 | 2.21 | 0.683 times |
06 Tue Aug 2024 | 2.35 | 2.22 | 2.35 | 2.21 | 0.539 times |
My analysis of stock is bearish for shortterm, and stock might move down till 2.3 or till 2.1. Use a stoploss of 2.4 and if the stock hits stoploss, then it can shoot up till 2.52
Share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Target | 2.00 |
Downside Target | 2.10 |
Downside Target | 2.23 |
Downside Target | 2.28 |
Upside Target | 2.40 |
Upside Target | 2.52 |
Upside Target | 2.55 |
Upside Target | 2.60 |
Upside Target | 2.67 |
Upside Target | 2.78 |
Upside Target | 2.95 |
Intraday share price targets for Oramed Pharmaceuticals (ORMP)
Target Type | Value |
Downside Intraday Target | 2.31 |
Downside Intraday Target | 2.24 |
Upside Intraday Target | 2.44 |
Upside Intraday Target | 2.5 |
Upside Intraday Target | 2.37 |
Weekly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Weekly Closing Price | Open | High | Low | Volume |
19 Mon Aug 2024 | 2.37 | 2.34 | 2.44 | 2.31 | 0.167 times |
16 Fri Aug 2024 | 2.34 | 2.26 | 2.48 | 2.23 | 1.337 times |
09 Fri Aug 2024 | 2.34 | 2.13 | 2.40 | 2.10 | 0.874 times |
02 Fri Aug 2024 | 2.34 | 2.55 | 2.60 | 2.28 | 1.596 times |
26 Fri Jul 2024 | 2.60 | 2.55 | 2.67 | 2.52 | 1.022 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Oramed Pharmaceuticals (ORMP)
Date | Monthly Closing Price | Open | High | Low | Volume |
19 Mon Aug 2024 | 2.37 | 2.46 | 2.52 | 2.10 | 0.859 times |
31 Wed Jul 2024 | 2.55 | 2.56 | 2.67 | 2.35 | 0.455 times |
28 Fri Jun 2024 | 2.57 | 2.17 | 2.78 | 2.00 | 2.118 times |
31 Fri May 2024 | 2.18 | 2.29 | 2.55 | 2.15 | 0.864 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Oramed Pharmaceuticals (ORMP)
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color Prices appear to be moving up
CCI has generated a SELL signal for Oramed Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.32 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color Prices appear to be moving up
CCI has generated a SELL signal for Oramed Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.32 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.